Recent social science scholarship has employed the term “pharmaceuticalization” in analyses of the production, circulation and use of drugs. In this paper, we seek to open up further discussion of the scope, limits and potential of this as an analytical device through consideration of the role of law and legal processes in directing pharmaceutical flows. To do so, we synthesize a range of empirical and conceptual work concerned with the relationships between access to medicines and intellectual property law. This paper suggests that alongside documenting the expansion or reduction in demand for particular drugs, analysts of pharmaceuticalization attend to the ways in which socio-legal developments change (or not) the identities of drugs, and the means through which they circulate and come to be used by states and citizens. Such scholarship has the potential to more precisely locate the biopolitical processes that shape international agendas and targets, form markets, and produce health.

中文翻译：

---

国际法、公共卫生和制药的含义


最近的社会科学学术界在分析药物的生产、流通和使用时使用了“药物化”一词。在本文中，我们试图通过考虑法律和法律程序在指导药品流动中的作用，进一步讨论其作为分析工具的范围、限制和潜力。为此，我们综合了一系列有关药品获取与知识产权法之间关系的实证和概念工作。本文建议，除了记录特定药物需求的扩大或减少之外，药物化分析师还应关注社会法律发展改变（或不改变）药物特性的方式，以及它们流通和形成的方式。供国家和公民使用。这种学术研究有可能更准确地定位塑造国际议程和目标、形成市场和产生健康的生命政治进程。